MJP Associates’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,726
Closed -$605K 249
2025
Q4
$605K Buy
1,726
+11
+0.6% +$3.72K 0.08% 111
2025
Q3
$554K Buy
1,715
+188
+12% +$58.5K 0.07% 118
2025
Q2
$594K Buy
1,527
+1,036
+211% +$417K 0.09% 105
2025
Q1
$213K Buy
+491
New +$197K 0.04% 212
2024
Q3
Sell
-376
Closed -$204K 226
2024
Q2
$204K Buy
+376
New +$199K 0.04% 224

Other funds holding ELV

MJP Associates's ELV Position: Q1 2026 in Review

MJP Associates sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,726 shares — an estimated $605K sold.

MJP Associates first reported a position in ELV in Q2 2024 and held it in 5 quarters. The position peaked at $605K in Q4 2025. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • MJP Associates reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • MJP Associates sold 1,726 Elevance Health shares in Q1 2026, an estimated $605K.
  • MJP Associates first reported a position in Elevance Health in Q2 2024 and held it in 5 quarters.
  • MJP Associates's Elevance Health position peaked at $605K in Q4 2025.
  • 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.